Seoul Pharma Co. Ltd (018680) — Free Cash Flow Generation Index
Seoul Pharma Co. Ltd (018680) has a Free Cash Flow Generation Index of 0.96x as of June 2025. Free cash flow of ₩1.98 Billion represents 1% of operating cash flow (₩2.07 Billion). See Seoul Pharma Co. Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Seoul Pharma Co. Ltd Free Cash Flow Generation Index (2009–2023)
Historical FCF Generation Index trend for Seoul Pharma Co. Ltd across 8 annual periods. Explore Seoul Pharma Co. Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Seoul Pharma Co. Ltd (2009–2023)
Year-by-year Free Cash Flow Generation Index for Seoul Pharma Co. Ltd. For the full company profile including market capitalisation, see 018680 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.64x | ₩3.37 Billion | ₩5.26 Billion | ₩1.89 Billion | ▼ -27.5% |
| 2020 | 0.88x | ₩5.07 Billion | ₩5.74 Billion | ₩671.25 Million | ▼ -16.2% |
| 2019 | 1.05x | ₩3.09 Billion | ₩2.93 Billion | ₩156.43 Million | ▼ -46.9% |
| 2015 | 1.98x | ₩2.82 Billion | ₩1.42 Billion | ₩1.40 Billion | ▼ -28.5% |
| 2014 | 2.77x | ₩4.10 Billion | ₩1.48 Billion | ₩2.62 Billion | ▼ -5.9% |
| 2012 | 2.95x | ₩27.17 Billion | ₩9.22 Billion | ₩17.95 Billion | ▲ +39.1% |
| 2011 | 2.12x | ₩10.29 Billion | ₩4.86 Billion | ₩5.43 Billion | ▼ -64.4% |
| 2009 | 5.95x | ₩7.34 Billion | ₩1.23 Billion | ₩6.11 Billion | — |